Wu Y, Xiong T, Tan X, Chen L (2022) Frailty and risk of microvascular complications in patients with type 2 diabetes: a population-based cohort study. BMC Med 20:473. https://doi.org/10.1186/s12916-022-02675-9

Article  PubMed  PubMed Central  Google Scholar 

Zelnick LR, Weiss NS, Kestenbaum BR et al (2017) Diabetes and CKD in the United States Population, 2009–2014. Clin J Am Soc Nephrol 12:1984–1990. https://doi.org/10.2215/CJN.03700417

Article  PubMed  PubMed Central  Google Scholar 

GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 395:709–733. https://doi.org/10.1016/S0140-6736(20)30045-3

Article  Google Scholar 

Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L et al (2020) Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci 21:3798. https://doi.org/10.3390/ijms21113798

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li Y, Wang L, Zhang J et al (2023) Integrated multi-omics and bioinformatic methods to reveal the mechanisms of sinomenine against diabetic nephropathy. BMC Complement Med Ther 23:287. https://doi.org/10.1186/s12906-023-04119-0

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mohanraj N, Prasanth S, Rajapriya P et al (2023) Bisphenol a accelerates the vascular complications in patients with Type 2 diabetes mellitus through vascular calcification-a molecular approach. Int Arch Occup Environ Health 96:1291–1299. https://doi.org/10.1007/s00420-023-02007-1

Article  PubMed  CAS  Google Scholar 

AlTamimi JZ, AlFaris NA, Alshammari GM et al (2023) Protective effect of eriodictyol against hyperglycemia-induced diabetic nephropathy in rats entails antioxidant and anti-inflammatory effects mediated by activating Nrf2. Saudi Pharm J 31:101817. https://doi.org/10.1016/j.jsps.2023.101817

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feigerlová E, Battaglia-Hsu S-F (2017) IL-6 signaling in diabetic nephropathy: from pathophysiology to therapeutic perspectives. Cytokine Growth Factor Rev 37:57–65. https://doi.org/10.1016/j.cytogfr.2017.03.003

Article  PubMed  CAS  Google Scholar 

Zhu H-M, Liu N, Sun D-X, Luo L (2023) Machine-learning algorithm-based prediction of a diagnostic model based on oxidative stress-related genes involved in immune infiltration in diabetic nephropathy patients. Front Immunol 14:1202298. https://doi.org/10.3389/fimmu.2023.1202298

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jin J, Wang L, Liu Y et al (2022) Depiction of immune heterogeneity of peripheral blood from patients with type II diabetic nephropathy based on mass cytometry. Front Endocrinol (Lausanne) 13:1018608. https://doi.org/10.3389/fendo.2022.1018608

Article  PubMed  Google Scholar 

Barutta F, Bruno G, Grimaldi S, Gruden G (2015) Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. Endocrine 48:730–742. https://doi.org/10.1007/s12020-014-0437-1

Article  PubMed  CAS  Google Scholar 

Wang X, Gao Y, Yi W et al (2021) Inhibition of miRNA-155 alleviates high glucose-induced podocyte inflammation by targeting SIRT1 in diabetic mice. J Diabetes Res 2021:5597394. https://doi.org/10.1155/2021/5597394

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng B, Lu Y, Ye L et al (2022) Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy. Front Endocrinol (Lausanne) 13:1043174. https://doi.org/10.3389/fendo.2022.1043174

Article  PubMed  Google Scholar 

Sakaue S, Kanai M, Tanigawa Y et al (2021) A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 53:1415–1424. https://doi.org/10.1038/s41588-021-00931-x

Article  PubMed  CAS  Google Scholar 

Zhao JH, Stacey D, Eriksson N et al (2023) Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol 24:1540–1551. https://doi.org/10.1038/s41590-023-01588-w

Article  PubMed  PubMed Central  CAS  Google Scholar 

Orrù V, Steri M, Sidore C et al (2020) Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet 52:1036–1045. https://doi.org/10.1038/s41588-020-0684-4

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yeung CHC, Schooling CM (2021) Systemic inflammatory regulators and risk of Alzheimer’s disease: a bidirectional Mendelian-randomization study. Int J Epidemiol 50:829–840. https://doi.org/10.1093/ije/dyaa241

Article  PubMed  Google Scholar 

Xiang M, Wang Y, Gao Z et al (2022) Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a Mendelian randomization. Front Immunol 13:985729. https://doi.org/10.3389/fimmu.2022.985729

Article  PubMed  CAS  Google Scholar 

Palmer TM, Lawlor DA, Harbord RM et al (2012) Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Method Med Res 21:223–242. https://doi.org/10.1177/0962280210394459

Article  Google Scholar 

Verbanck M, Chen C-Y, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet 50:693–698. https://doi.org/10.1038/s41588-018-0099-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sproviero W, Winchester L, Newby D et al (2021) High blood pressure and risk of dementia: a two-sample Mendelian randomization study in the UK Biobank. Biol Psychiatry 89:817–824. https://doi.org/10.1016/j.biopsych.2020.12.015

Article  PubMed  Google Scholar 

Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32:377–389. https://doi.org/10.1007/s10654-017-0255-x

Article  PubMed  PubMed Central  Google Scholar 

Min J-K, Kim Y-M, Kim SW et al (2005) TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells. J Immunol 175:531–540. https://doi.org/10.4049/jimmunol.175.1.531

Article  PubMed  CAS  Google Scholar 

Chen X-W, Du X-Y, Wang Y-X et al (2016) Irbesartan ameliorates diabetic nephropathy by suppressing the RANKL-RANK-NF-κB pathway in type 2 diabetic db/db mice. Mediators Inflamm 2016:1405924. https://doi.org/10.1155/2016/1405924

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ke G, Chen X, Liao R et al (2021) Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy. Kidney Int 100:377–390. https://doi.org/10.1016/j.kint.2021.04.036

Article  PubMed  CAS  Google Scholar 

Mauri DN, Ebner R, Montgomery RI et al (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21–30. https://doi.org/10.1016/s1074-7613(00)80455-0

Article  PubMed  CAS  Google Scholar 

Halvorsen B, Santilli F, Scholz H et al (2016) LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro. Diabetologia 59:2134–2144. https://doi.org/10.1007/s00125-016-4036-y

Article  PubMed  PubMed Central  CAS